Page 2 - Regenerative Engineering News Today

/PRNewswire/ -- The Intellectual Property Owners Education Foundation (IPOEF) awards the prestigious Inventor of the Year award to Dr. Cato T. Laurencin for...

/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) (the Company) today issued a letter to its shareholders in connection with the Companys upcoming 2023 Annual...

Sarissa's Proposed Candidates Would Not Bring New Skills to the Board Recommends Shareholders Vote "FOR" Alkermes' Director Nominees on Company's WHITE Proxy Card DUBLIN, June 13,

THE success story of INVICTUS is found on the centre pages of this issue of the newspaper. In light of this success...

Society for Science alumna Anjali Chadha, Kavya Kopparapu, Magan Lewis and Erin Smith spoke with Nicole Small, CEO of LH Capital, Inc. and Lyda Hill Philanthropies, during the Women in STEM panel at Regeneron ISEF 2023.

Researchers have examined a specific type of stem cell with an intracellular toolkit to determine which cells are most likely to create effective cell therapies.

In two papers out of the lab of Ahmet F. Coskun, researchers at the Georgia Institute of Technology and Emory University examined a specific type of stem cell with an intracellular toolkit to determine which cells are most likely to create effective cell therapies.

Researchers have developed an intracellular toolkit to study organelle communication and diversity within stem cells, combining rapid proteomic imaging, immunofluorescence techniques, and spatial transcriptomics. This toolkit allows for more accurate cell type classification and could lead to improv

UConn Health recently removed signs that commemorated donations by two late Sackler family members who co-owned OxyContin maker Purdue Pharma.

/PRNewswire/ -- The "Innovations in Flow Cytometry 2023" conference has been added to ResearchAndMarkets.coms offering. Welcome to the Innovations in Flow...